Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline

Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Frequent injection of drug decreases patients’ compliance. The present study describes the formulation of a sustained rel...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mahboubian, Alireza, Hashemein, Seyyed Kazem, Moghadam, Shadi, Atyabi, Fatemeh, Dinarvand, Rassoul
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Shaheed Beheshti University of Medical Sciences 2010
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870060/
https://ncbi.nlm.nih.gov/pubmed/24381601
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller